Press release
Lawsuit filed for Investors in shares of Stem, Inc. (NYSE: STEM) over alleged Securities Laws Violations

A lawsuit was filed on behalf of investors in Stem, Inc. (NYSE: STEM) shares over alleged securities laws violations.
Investors who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and for certain investors are short and strict deadlines running. Deadline: July 11, 2023. NYSE: STEM investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
San Francisco, CA based Stem, Inc. operates as a digitally connected and intelligent energy storage network provider in the United States and internationally. On December 4, 2020 Stem, Inc. announced that it had entered into a definitive agreement to merge with Star Peak Energy Transition Corp., a special purpose acquisition corporation (known as a SPAC or blank-check company), that would result in a combined company with an estimated equity value of approximately $1.35 billion.
On February 24, 2022, Stem, Inc. announced that it had entered into a strategic partnership with Available Power ("AP") with a "[v]alue of award expected to exceed $500 million across the project portfolio" and that "provide[d] Stem exclusive rights to 100 standalone energy storage projects in Texas".
On January 11, 2023, Blue Orca Capital ("Blue Orca") issued a report alleging undisclosed issues with Stem's business and financial prospects, including, among other things, that the Company had overstated its software revenues by falsely claiming that 100% of its services revenue line was attributable to software revenues. Thereafter, on January 12, 2023, Stem issued a response, purporting to refute Blue Orca's claims. In doing so, however, the Company never expressly refuted Blue Orca's claims that software revenue did not make up 100% of the Company's services revenue. Separately, Stem's response to the Blue Orca report clarified that the Company's "canceled . . . booking of approximately $135 million in the fourth quarter of 2022" - as first disclosed in Stem's January 5, 2023 investor presentation deck - was "attributable solely to DevCo projects with [AP]" and that "[w]e have not recorded any revenue from any [AP] projects and there are no additional projects in the backlog with this former partner."
Finally, on February 16, 2023, Stem, Inc. reported its 4Q 2022 results and 2023 guidance. The Company reported 4Q revenue of $156 million, versus consensus estimates of $166 million, and issued disappointing FY 2023 revenue guidance of $550 million to $650 million.
Shares of Stem, Inc. (NYSE: STEM) declined from $18.01 per share on September 15, 2022, to as low as $3.715 per share on May 2, 2023.
The plaintiff claims that, the Offering Documents that were filed in connection with the Merger and that the Defendants between March 4, 2021 and February 16, 2023 made false and/or misleading statements and/or failed to disclose that, Legacy Stem suffered from material weaknesses in internal control over financial reporting related to accounting for deferred cost of goods sold and inventory, certain revenue recognition calculations, and internal-use capitalized software calculations;, that the Company had overstated Legacy Stem's and its own post-Merger business and financial prospects, that Stem's software revenue did not make up 100% of the Company's services revenue, that Stem had overstated the benefits expected to flow from its AP partnership, and that as a result, the Offering Documents and Defendants' public statements between March 4, 2021 and February 16, 2023 were materially false and/or misleading and failed to state information required to be stated therein.
Those who purchased shares of Stem, Inc. (NYSE: STEM) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors in shares of Stem, Inc. (NYSE: STEM) over alleged Securities Laws Violations here
News-ID: 3062984 • Views: …
More Releases from Shareholders Foundation

ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…

Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…

Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…

Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Stem
Animal Stem Cell Therapy Market Worth Observing Growth| Cell Therapy Sciences, M …
Advance Market Analytics published a new research publication on "Animal Stem Cell Therapy Market Insights, to 2030" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Stem Cell Therapy market was mainly driven by the increasing R&D spending across the world. Some of…
Introducing My STEM Resume: The Ultimate Solution for STEM Professionals
As STEM industries continue to grow, so does the demand for qualified professionals. Yet, many STEM students and professionals face challenges in effectively showcasing their skills and experience to prospective employers. Recognizing this need, Brendon, a seasoned STEM professional, has developed a groundbreaking solution: My STEM Resume.
My STEM Resume is a cutting-edge app designed specifically for STEM professionals, offering a comprehensive suite of tools to streamline the resume creation and…
Animal Stem Cell Therapy Market 2022: Allogeneic Stem Cells Popular Sourcing Cho …
The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032).
Request For Free Sample Report of "Animal Stem Cell Therapy Market"@ https://www.persistencemarketresearch.com/samples/14941
Animal stem cell therapies are treatments for disorders such as arthritis, soft tissue injuries, traumatic fractures, tendonitis, inflammatory bowel disease, and others that…
Animal Stem Cell Therapy Market 2021 Research Report by Experts- Magellan Stem C …
Global Animal Stem Cell Therapy Market Size, Status and Forecast 2022
The Global Animal Stem Cell Therapy Market Research Report 2022-2027 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Market study provides comprehensive…
Stem Cells Market: Development of Infrastructure to Drive Global Stem Cells Mark …
In the global stem cells market a sizeable proportion of companies are trying to garner investments from organizations based overseas. This is one of the strategies leveraged by them to grow their market share. Further, they are also forging partnerships with pharmaceutical organizations to up revenues.
Read Report Overview - https://www.transparencymarketresearch.com/stem-cells-market.html
In addition, companies in the global stem cells market are pouring money into expansion through multidisciplinary and multi-sector collaboration for large…
Global Animal Stem Cell Therapy Market Detailed Analysis 2018-2025 : MediVet Bio …
Qyresearchreports include new market research report “Global Animal Stem Cell Therapy Market Research Report 2018” to its huge collection of research reports.
Animal stem cell therapy is a usage of animals stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process…